Dishman Carbogen [DCAL] vs Titan Bio-Tech [TITANBIO] Detailed Stock Comparison

Dishman Carbogen Amcis Ltd.

NSE
Loading...

Titan Bio-Tech Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dishman Carbogen Amcis Ltd. wins in 10 metrics, Titan Bio-Tech Ltd. wins in 8 metrics, with 0 ties. Dishman Carbogen Amcis Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dishman Carbogen Amcis Ltd. Titan Bio-Tech Ltd. Better
P/E Ratio (TTM) 22.30 74.64 Dishman Carbogen Amcis Ltd.
Price-to-Book Ratio 0.42 12.19 Dishman Carbogen Amcis Ltd.
Debt-to-Equity Ratio 40.20 5.32 Titan Bio-Tech Ltd.
PEG Ratio -0.16 -1.22 Dishman Carbogen Amcis Ltd.
EV/EBITDA 9.62 61.34 Dishman Carbogen Amcis Ltd.
Profit Margin (TTM) 4.25% 14.13% Titan Bio-Tech Ltd.
Operating Margin (TTM) 3.99% 16.92% Titan Bio-Tech Ltd.
EBITDA Margin (TTM) 3.99% 16.92% Titan Bio-Tech Ltd.
Return on Equity 0.06% 14.04% Titan Bio-Tech Ltd.
Return on Assets (TTM) 0.03% 12.32% Titan Bio-Tech Ltd.
Free Cash Flow (TTM) $1.58B $106.79M Dishman Carbogen Amcis Ltd.
Dividend Yield N/A 0.42% N/A
1-Year Return -33.95% 419.45% Titan Bio-Tech Ltd.
Price-to-Sales Ratio (TTM) 0.95 10.54 Dishman Carbogen Amcis Ltd.
Enterprise Value $46.55B $20.35B Dishman Carbogen Amcis Ltd.
EV/Revenue Ratio 1.66 10.57 Dishman Carbogen Amcis Ltd.
Gross Profit Margin (TTM) 80.34% N/A N/A
Revenue per Share (TTM) $179 $47 Dishman Carbogen Amcis Ltd.
Earnings per Share (Diluted) $7.58 $6.58 Dishman Carbogen Amcis Ltd.
Beta (Stock Volatility) 0.40 -0.48 Titan Bio-Tech Ltd.

Dishman Carbogen Amcis Ltd. vs Titan Bio-Tech Ltd. Stock Performance Analysis

Loading Price Chart...

DCAL
TITANBIO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dishman Carbogen Amcis Ltd.-2.38%-2.24%-7.21%9.02%-19.76%-29.73%
Titan Bio-Tech Ltd.0.80%3.09%-1.02%28.03%96.24%110.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dishman Carbogen Amcis Ltd.-33.95%46.77%-6.77%33.46%290.77%118.12%
Titan Bio-Tech Ltd.419.45%756.94%499.88%6,742.31%9,962.22%20,395.39%

Performance & Financial Health Analysis: Dishman Carbogen Amcis Ltd. vs Titan Bio-Tech Ltd.

MetricDCALTITANBIO
Market Information
Market Cap i₹26.50B₹19.90B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i337,26468,890
90 Day Avg. Volume i517,904156,601
Last Close₹180.24₹448.30
52 Week Range₹128.50 - ₹321.95₹74.73 - ₹555.65
% from 52W High-44.02%-19.32%
All-Time High₹396.40 (Jan 22, 2018)₹1,460.00 (Feb 18, 2026)
% from All-Time High-54.53%-69.29%
Growth Metrics
Quarterly Revenue Growth0.06%0.48%
Quarterly Earnings Growth-0.09%0.94%
Financial Health
Profit Margin (TTM) i0.04%0.14%
Operating Margin (TTM) i0.04%0.17%
Return on Equity (TTM) i0.00%0.14%
Debt to Equity (MRQ) i40.205.32
Cash & Liquidity
Book Value per Share (MRQ)₹405.67₹40.29
Cash per Share (MRQ)₹40.41₹0.87
Operating Cash Flow (TTM) i₹-199,700,000₹197.75M
Levered Free Cash Flow (TTM) i₹32.40M₹215.32M
Dividends
Last 12-Month Dividend Yield iN/A0.42%
Last 12-Month Dividend i₹0.00₹4.00

Valuation & Enterprise Metrics Analysis: Dishman Carbogen Amcis Ltd. vs Titan Bio-Tech Ltd.

MetricDCAL (Apr 26, 2026)TITANBIO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i22.3074.64
Forward P/E i13.52N/A
PEG Ratio i-0.16-1.22
Price to Sales (TTM) i0.9510.54
Price to Book (MRQ) i0.4212.19
Market Capitalization
Market Capitalization i₹26.50B₹19.90B
Enterprise Value i₹46.55B₹20.35B
Enterprise Value Metrics
Enterprise to Revenue i1.6610.57
Enterprise to EBITDA i9.6261.34
Risk & Other Metrics
Beta i0.40-0.48
Book Value per Share (MRQ) i₹405.67₹40.29

Financial Statements Comparison: Dishman Carbogen Amcis Ltd. vs Titan Bio-Tech Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDCAL (2025)TITANBIO (2025)
Revenue/Sales i26.42B1.56B
Cost of Goods Sold i5.26B892.53M
COGS % of Revenue i19.9%57.0%
Gross Profit i21.16B671.98M
Gross Margin i80.1%43.0%
Research & Development iN/AN/A
Operating Income (EBIT) i1.46B212.57M
Operating Margin i5.5%13.6%
EBITDA i4.83B285.61M
EBITDA Margin i18.3%18.3%
Pre-Tax Income i193.10M243.67M
Pre-Tax Income % of Revenue i0.7%15.6%
Income Tax i160.70M60.96M
Income Tax % of Revenue i0.6%3.9%
Net Income (Profit) i32.40M215.32M
Profit Margin i0.1%13.8%

Balance Sheet & Liquidity Metrics

MetricDCAL (2025)TITANBIO (2025)
Cash & Equivalents i2.86B51.28M
Total Current Assets i22.00B790.38M
Total Current Assets % of Revenue i83.3%50.5%
Total Current Liabilities i19.25B177.36M
Total Current Liabilities % of Revenue i72.9%11.3%
Long-Term Debt i13.90B4.19M
Long-Term Debt % of Revenue i52.6%0.3%
Total Shareholders Equity i58.32B1.53B
Retained Earnings i2.13B1.36B
Retained Earnings % of Revenue i8.1%87.0%
Property, Plant & Equipment i10.27B571.62M

Cash Flow Statement Comparison

MetricDCAL (2025)TITANBIO (2025)
Operating Cash Flow i-199.70M197.75M
Operating Cash Flow % of Revenue i-0.8%12.6%
Capital Expenditures i-2.15B-85.26M
Free Cash Flow i1.58B106.79M
FCF Margin i6.0%6.8%
Debt Repayment i-1.10B-2.69M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDCALTITANBIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i156.78M41.32M
Float Shares i54.95M13.13M
% Held by Insiders i69.30%68.21%
% Held by Institutions i2.41%0.00%
% Held by Public i28.29%31.79%

Dividend Analysis & Yield Comparison: Dishman Carbogen Amcis Ltd. vs Titan Bio-Tech Ltd.

MetricDCALTITANBIO
Last 12-Month Dividend i₹0.00₹4.00
Last 12-Month Dividend Yield iN/A0.42%
3-Year Avg Annual Dividend i₹0.00₹1.93
3-Year Avg Dividend Yield iN/A0.34%
3-Year Total Dividends i₹0.00₹5.80
Ex-Dividend DateN/ASep 19, 2025